These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27498157)

  • 21. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
    Chen W; Zou Y; Zhong Z; Haag R
    Small; 2017 Feb; 13(6):. PubMed ID: 27865044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the TGFβ pathway in the regulation of α5 β1 integrins by caveolin-1 in human glioblastoma.
    Cosset EC; Godet J; Entz-Werlé N; Guérin E; Guenot D; Froelich S; Bonnet D; Pinel S; Plenat F; Chastagner P; Dontenwill M; Martin S
    Int J Cancer; 2012 Aug; 131(3):601-11. PubMed ID: 21901744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling Determinants of Glioma Cell Invasion.
    Kwiatkowska A; Symons M
    Adv Exp Med Biol; 2020; 1202():129-149. PubMed ID: 32034712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.
    Koch K; Hartmann R; Schröter F; Suwala AK; Maciaczyk D; Krüger AC; Willbold D; Kahlert UD; Maciaczyk J
    Oncotarget; 2016 Nov; 7(45):73414-73431. PubMed ID: 27705917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
    Piao Y; Park SY; Henry V; Smith BD; Tiao N; Flynn DL; de Groot JF
    Neuro Oncol; 2016 Sep; 18(9):1230-41. PubMed ID: 26965451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB.
    Monferran S; Skuli N; Delmas C; Favre G; Bonnet J; Cohen-Jonathan-Moyal E; Toulas C
    Int J Cancer; 2008 Jul; 123(2):357-364. PubMed ID: 18464290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
    Hoelzinger DB; Demuth T; Berens ME
    J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic Supplemental Treatment for Glioblastoma.
    Shah S; Mansour HM; Aguilar TM; Lucke-Wold B
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma.
    Iwadate Y; Matsutani T; Hirono S; Shinozaki N; Saeki N
    J Neurooncol; 2016 Aug; 129(1):101-7. PubMed ID: 27193555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The sodium pump could constitute a new target to combat glioblastomas].
    Lefranc F; Mijatovic T; Kiss R
    Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel interaction of PAK4 with PPARγ to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma.
    Kesanakurti D; Maddirela D; Banasavadi-Siddegowda YK; Lai TH; Qamri Z; Jacob NK; Sampath D; Mohanam S; Kaur B; Puduvalli VK
    Oncogene; 2017 Sep; 36(37):5309-5320. PubMed ID: 28534509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy.
    Liang J; Piao Y; Henry V; Tiao N; de Groot JF
    Oncotarget; 2015 Oct; 6(31):31479-92. PubMed ID: 26362401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition.
    Lin JJ; Zhao TZ; Cai WK; Yang YX; Sun C; Zhang Z; Xu YQ; Chang T; Li ZY
    Oncotarget; 2015 Jul; 6(19):17107-20. PubMed ID: 25940798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
    Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
    Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenic inhibition in high-grade gliomas: past, present and future.
    Jo J; Schiff D; Purow B
    Expert Rev Neurother; 2012 Jun; 12(6):733-47. PubMed ID: 22650175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proneural-mesenchymal transformation of glioma stem cells: do therapies cause evolution of target in glioblastoma?
    Nakano I
    Future Oncol; 2014; 10(9):1527-30. PubMed ID: 25145421
    [No Abstract]   [Full Text] [Related]  

  • 40. Signal transduction inhibitors and antiangiogenic therapies for malignant glioma.
    Mellinghoff IK; Lassman AB; Wen PY
    Glia; 2011 Aug; 59(8):1205-12. PubMed ID: 21351155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.